Other equities research analysts have also issued reports about the stock. TheStreet raised shares of athenahealth from a c rating to a b- rating in a report on Thursday, July 20th. Citigroup Inc. reissued a buy rating and issued a $169.00 target price (up from $163.00) on shares of athenahealth in a report on Monday, July 10th. Dougherty & Co increased their target price on shares of athenahealth from $123.00 to $148.00 and gave the stock a buy rating in a report on Tuesday, May 23rd. UBS AG reissued a buy rating and issued a $152.00 target price (up from $123.00) on shares of athenahealth in a report on Wednesday, May 31st. Finally, BidaskClub raised shares of athenahealth from a hold rating to a buy rating in a report on Saturday, June 24th. Three equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and twelve have issued a buy rating to the company. The company currently has a consensus rating of Hold and an average target price of $149.91.
athenahealth (NASDAQ ATHN) opened at 124.38 on Friday. athenahealth has a 52 week low of $90.11 and a 52 week high of $158.66. The company’s 50-day moving average is $138.24 and its 200 day moving average is $129.15. The stock has a market cap of $4.97 billion, a PE ratio of 157.84 and a beta of 1.79.
athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The firm had revenue of $301.10 million for the quarter, compared to analysts’ expectations of $298.68 million. During the same quarter in the prior year, the business earned $0.34 EPS. The business’s quarterly revenue was up 15.0% on a year-over-year basis. On average, analysts expect that athenahealth will post $1.91 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://ledgergazette.com/2017/09/20/athenahealth-inc-athn-earns-buy-rating-from-keycorp.html.
In related news, CEO Jonathan Bush sold 4,000 shares of the firm’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $140.52, for a total value of $562,080.00. Following the completion of the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $44,939,279.64. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Jonathan D. Porter sold 422 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $154.00, for a total transaction of $64,988.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,722 shares of company stock valued at $2,221,721. 3.20% of the stock is currently owned by insiders.
Several hedge funds have recently bought and sold shares of ATHN. Janus Henderson Group PLC purchased a new position in shares of athenahealth in the second quarter valued at $713,856,000. BlackRock Inc. grew its holdings in shares of athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock valued at $180,286,000 after purchasing an additional 1,594,643 shares in the last quarter. Morgan Stanley grew its holdings in shares of athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after purchasing an additional 397,837 shares in the last quarter. Elliott Management Corp purchased a new position in shares of athenahealth in the second quarter valued at $52,706,000. Finally, Clearbridge Investments LLC grew its holdings in shares of athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock valued at $102,379,000 after purchasing an additional 347,133 shares in the last quarter.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.